Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Ascending
Jan 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 3,786 n/a
Mar 30, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,852 n/a
Jul 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,860 n/a
Jul 24, 2012 vagelos p roy Officer Disposition (Non Open Market) 59,841 n/a
Jan 12, 2011 vagelos p roy Officer Disposition (Non Open Market) 1,203 n/a
Jan 12, 2011 vagelos p roy Officer Acquisition (Non Open Market) 1,203 n/a
Apr 4, 2011 vagelos p roy Officer Disposition (Non Open Market) 4,954 n/a
Jun 20, 2011 vagelos p roy Officer Automatic Buy 30,778 n/a
Jun 20, 2011 vagelos p roy Officer Automatic Sell 30,778 n/a
Jun 30, 2011 vagelos p roy Officer Disposition (Non Open Market) 3,798 n/a
Jun 18, 2010 vagelos p roy Director Acquisition (Non Open Market) 31,761 n/a
Jun 18, 2010 vagelos p roy Director Disposition (Non Open Market) 31,761 n/a
Jul 2, 2010 vagelos p roy Director Disposition (Non Open Market) 9,021 n/a
Jul 7, 2010 vagelos p roy Director Disposition (Non Open Market) 125,000 n/a
Jul 7, 2010 vagelos p roy Director Acquisition (Non Open Market) 125,000 n/a
Oct 4, 2010 vagelos p roy Director Disposition (Non Open Market) 8,035 n/a
Jul 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,837 n/a
Oct 5, 2009 vagelos p roy Director Disposition (Non Open Market) 10,796 n/a
Dec 17, 2007 yancopoulos george Officer Acquisition (Non Open Market) 500,000 n/a
Jun 27, 2012 yancopoulos george Officer Acquisition (Non Open Market) 500,000 n/a
Showing 101-120 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)